The Lyme Disease Biobank: Characterization of 550 Patient and Control Samples from the East Coast and Upper Midwest of the United States

Lyme disease (LD) is an increasing public health problem. Current laboratory testing is insensitive in early infection, the stage at which appropriate treatment is most effective in preventing disease sequelae. The Lyme Disease Biobank (LDB) collects samples from individuals with symptoms consistent...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Microbiol
Auteurs principaux: Horn, Elizabeth J., Dempsey, George, Schotthoefer, Anna M., Prisco, U. Lena, McArdle, Matthew, Gervasi, Stephanie S., Golightly, Marc, De Luca, Cathy, Evans, Mel, Pritt, Bobbi S., Theel, Elitza S., Iyer, Radha, Liveris, Dionysios, Wang, Guiqing, Goldstein, Don, Schwartz, Ira
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2020
Sujets:
Immunoassays
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7269379/
https://ncbi.nlm.nih.gov/pubmed/32102853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.00032-20
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires